Showing results (281-290 of 298) with videos related to

Sort By:
Pageof 30
Journal of the American College of Radiology : JACR|November 27, 2022
ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update, Andrew D Smith, Paul Nikolaidis, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 6, 2006
Magnetic resonance imaging of Asians with multiple sclerosis was similar to that of the WestH T Chong, N Ramli, K H Lee, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 17, 2015
Knowledge Translation and Barriers to Imaging Optimization in the Emergency Department: A Research AgendaMarc A Probst, Peter S Dayan, Ali S Raja, et al.
Journal of the American College of Radiology : JACR|May 7, 2020
ACR Appropriateness Criteria® Seizures and Epilepsy, Ryan K Lee, Judah Burns, et al.
Journal of Medicinal Chemistry|March 12, 1999
Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responsesK c Lin, H S Ateeq, S H Hsiung, et al.
Scientific Reports|August 9, 2020
Tales of 1,008 small molecules: phenomic profiling through live-cell imaging in a panel of reporter cell linesMichael J Cox, Steffen Jaensch, Jelle Van de Waeter, et al.
Medicina (Kaunas, Lithuania)|July 30, 2025
Conduction System Pacing Versus Biventricular Cardiac Resynchronization Pacing: Meta-Analysis on Outcomes in Patients with Non-Left Bundle Branch BlockXuanming Pung, Joe J L Chua, Khi Yung Fong, et al.
Journal of Medicinal Chemistry|August 28, 1998
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide classS R Turner, J W Strohbach, R A Tommasi, et al.
Journal of Medicinal Chemistry|November 8, 1996
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.
Nature Communications|December 6, 2017
Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiformeJennifer P Newman, Grace Y Wang, Kazuhiko Arima, et al.
Pageof 30